Menu
GeneBe

19-11033308-C-T

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_001387283.1(SMARCA4):c.3565C>T(p.Arg1189Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 33)

Consequence

SMARCA4
NM_001387283.1 stop_gained

Scores

3
3
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 1.01
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-11033308-C-T is Pathogenic according to our data. Variant chr19-11033308-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 6554.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11033308-C-T is described in Lovd as [Likely_benign]. Variant chr19-11033308-C-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SMARCA4NM_001387283.1 linkuse as main transcriptc.3565C>T p.Arg1189Ter stop_gained 26/36 ENST00000646693.2
SMARCA4NM_003072.5 linkuse as main transcriptc.3565C>T p.Arg1189Ter stop_gained 26/35 ENST00000344626.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SMARCA4ENST00000646693.2 linkuse as main transcriptc.3565C>T p.Arg1189Ter stop_gained 26/36 NM_001387283.1
SMARCA4ENST00000344626.10 linkuse as main transcriptc.3565C>T p.Arg1189Ter stop_gained 26/351 NM_003072.5 P4P51532-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Rhabdoid tumor predisposition syndrome 2 Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingInvitaeSep 29, 2021This premature translational stop signal has been observed in individual(s) with rhabdoid tumor predisposition syndrome (PMID: 20137775). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Arg1189*) in the SMARCA4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SMARCA4 are known to be pathogenic (PMID: 24658001, 24658002). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 6554). -
Pathogenic, no assertion criteria providedliterature onlyOMIMFeb 12, 2010- -
Pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsDec 06, 2022- -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingGeneDxDec 19, 2018The R1189X variant in the SMARCA4 gene has been previously reported in two siblings with rhabdoid tumors (Schneppenheim 2010) as well as in a small cell carcinoma of the ovary, hypercalcemia type (Ramos 2014). This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R1189X variant is not observed in large population cohorts (Lek et al., 2016). Therefore, the R1189X variant is considered a pathogenic variant, and its presence is consistent with a SMARCA4-related disorder. -
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsAug 19, 2019The p.R1189* pathogenic mutation (also known as c.3565C>T), located in coding exon 25 of the SMARCA4 gene, results from a C to T substitution at nucleotide position 3565. This changes the amino acid from an arginine to a stop codon within coding exon 25. This mutation has been detected in two sisters with early-onset rhabdoid tumors and separately in a woman with small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) (Schneppenheim R et al. Am. J. Hum. Genet., 2010 Feb;86:279-84; Ramos P et al. Nat. Genet., 2014 May;46:427-9). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Pathogenic
0.63
Cadd
Pathogenic
46
Dann
Uncertain
1.0
Eigen
Pathogenic
0.73
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Uncertain
0.92
D
MutationTaster
Benign
1.0
A;A;A;A;A;A;A;A;A
Vest4
0.98
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs267607070; hg19: chr19-11143984; COSMIC: COSV60811967; COSMIC: COSV60811967; API